KBC upgrades Corbion to 'buy' on new strategy

Corbion NV

27/11/2025 14:30

** Shares in Dutch food and biochemicals company Corbion CORB.AS rise 2% after KBC Securities upgrades its rating to "buy" from "accumulate" following a strategy update

** The broker notes the "2030 plan" sharpens Corbion's focus on food and nutrition, with biochemicals de-prioritised and a likely exit from the PLA joint venture

** KBC highlights new financial targets, including a 3-6% annual sales growth goal and a rise in its adjusted EBITDA margin to 18% by 2028 from 16.3% currently

** It expects disciplined capex and improving profitability to allow for higher dividends and buybacks

** "Corbion is clearly discounted vs food ingredient peers," the broker adds, noting its "leading" lactic acid technology and expecting lower input costs to boost 2026 earnings

** Out of eight analysts that cover Corbion, five rate the stock "strong buy" or "buy," and ​three rate it "hold" - LSEG data

(Reporting by Jerome Terroy)

((Jerome.terroyDimitri.rhodes@thomsonreuters.com))